Jason Barker is a seasoned finance executive, operational strategist, and trusted advisor whose career has been defined by helping organizations navigate periods of transformation, accelerated growth, and market evolution. With more than 25 years of experience spanning biotechnology, life sciences, software, high technology, and financial operations, he has built a reputation as a collaborative leader capable of aligning financial strategy with long-term business objectives. Throughout his career, Jason has consistently demonstrated the ability to guide companies through critical inflection points while maintaining a disciplined, forward-thinking approach to leadership and value creation.
Over the course of his professional journey, Jason has served in senior finance and operational leadership roles within both public and private organizations ranging from early-stage startups to Fortune 500 enterprises. His experience has positioned him at the center of some of the most important phases of corporate development, including IPO preparation, post-public-company scaling, capital formation, strategic partnerships, operational expansion, and financial restructuring. His ability to bridge operational execution with strategic finance has made him a valued leader among executive teams, boards of directors, investors, and stakeholders alike.
Currently serving as Fractional Chief Financial Officer for Incregen Therapeutics, Jason oversees finance operations while contributing to the organization’s broader corporate strategy and fundraising initiatives. In this role, he continues to leverage decades of financial leadership experience to help emerging biotechnology companies strengthen their operational infrastructure and position themselves for sustainable growth. His leadership style emphasizes transparency, collaboration, and pragmatic decision-making, enabling organizations to maintain agility while building long-term enterprise value.
Before joining Incregen Therapeutics, Jason spent nearly seven years with Arcus Biosciences as Vice President of Finance and Treasury. During his tenure, he managed a broad portfolio of responsibilities that included accounting, treasury, financial planning and analysis, tax, insurance, procurement, real estate, and global clinical trial contracting and outsourcing. He also served as Interim Chief Financial Officer during a critical transition period for the company, providing steady leadership while helping stabilize and reorganize finance operations amid substantial organizational growth and executive changes.
One of Jason’s most notable achievements at Arcus Biosciences was supporting the negotiation and execution of a landmark ten-year, $3 billion collaboration agreement with Gilead Sciences. In addition, he contributed to the successful completion of a $350 million equity financing transaction, reinforcing the company’s financial strength and strategic positioning within the biotechnology sector. His work extended beyond transactional finance, as he played a central role in long-range strategic planning, investor communications, treasury oversight, and operational scaling initiatives that supported the company’s growth from approximately 130 employees to more than 600 employees globally.
Jason’s earlier leadership experience at Audentes Therapeutics further solidified his expertise in scaling emerging biotechnology organizations. Serving as Vice President of Finance, he was instrumental in building the company’s finance and accounting function from the ground up while supporting the company’s successful IPO and subsequent public-market operations. He oversaw financial reporting, treasury, tax, payroll, governance, international operations, and risk management, while also leading the implementation of enterprise-wide ERP systems and supporting hundreds of millions of dollars in public and private financing transactions. His work helped position Audentes Therapeutics for rapid growth and operational maturity within the highly competitive gene therapy industry.
Throughout his career, Jason has repeatedly demonstrated an ability to build and mentor high-performing teams. Whether overseeing finance professionals, managing cross-functional operational groups, or partnering with executive leadership, he has consistently emphasized accountability, collaboration, and professional development. His leadership philosophy centers around creating environments where individuals are empowered to contribute strategically while maintaining operational discipline and integrity. Colleagues and peers recognize him not only for his technical expertise, but also for his calm demeanor, thoughtful leadership, and ability to navigate complex challenges with clarity and confidence.
In addition to his corporate leadership roles, Jason has extensive advisory experience through his work with Bauer York LLC, where he served as Principal and Managing Director. In this capacity, he provided fractional CFO and strategic consulting services to numerous biotechnology and technology companies. His advisory work focused on IPO readiness, finance infrastructure development, strategic modeling, operational planning, and transaction support. He advised companies on matters ranging from collaboration restructurings to financial modeling for commercial product launches, further expanding his perspective across multiple sectors and organizational stages.
Jason’s expertise extends deeply into treasury management, risk mitigation, strategic financial planning, fundraising, and operational finance. Over the years, he has negotiated and structured venture debt arrangements, overseen billion-dollar investment portfolios, managed complex real estate portfolios, and participated in M&A evaluations and due diligence efforts. His ability to combine financial rigor with strategic insight has enabled organizations to navigate volatile markets, capitalize on growth opportunities, and strengthen their long-term competitive positioning.
Beyond his technical capabilities, Jason is deeply motivated by the opportunity to help organizations solve problems, grow responsibly, and create lasting impact. He is particularly passionate about working with innovative companies whose technologies and services improve lives, advance healthcare, or transform industries. As he increasingly transitions toward board service and advisory leadership, he brings with him decades of practical executive experience, governance exposure, and a strong understanding of how businesses evolve through various stages of growth and complexity.
Jason’s educational foundation was established at the University of Texas at Arlington, where he earned a Bachelor of Arts degree in Finance, Accounting, and Business Law with honors. He has also maintained active involvement within industry organizations, including the Association of Bioscience Financial Officers and BayBIO, where he previously served on the Government Relations Committee. These experiences have strengthened his understanding of industry dynamics, policy considerations, and the broader financial and operational challenges facing growth-oriented organizations.
Today, Jason Barker is recognized as a respected finance executive and strategic advisor whose career reflects a unique balance of operational leadership, financial sophistication, and business partnership. His experience guiding organizations through IPOs, strategic transactions, operational scaling, and corporate transformation has established him as a trusted voice in both the biotechnology and technology sectors. As he continues expanding his board and advisory involvement, Jason remains committed to helping organizations strengthen governance, execute growth strategies, and build enduring enterprise value through disciplined leadership and collaborative problem-solving.
Character:
Jason Barker demonstrates integrity and professionalism in every leadership role he undertakes. He is widely respected for his steady demeanor, thoughtful judgment, and ability to lead organizations through periods of uncertainty with confidence and composure. His commitment to mentoring teams and fostering collaborative environments reflects a leadership style grounded in trust, accountability, and respect for others.
Knowledge:
He possesses deep expertise across finance, treasury, operational scaling, public-company reporting, and strategic planning. His experience spans multiple industries, including biotechnology, life sciences, software, and technology, giving him a broad and adaptable business perspective. He combines technical financial knowledge with operational insight, allowing him to contribute meaningfully to both strategic discussions and day-to-day execution.
Strategic:
Jason has consistently helped organizations navigate transformational growth, complex financing environments, and long-term planning initiatives. He understands how to align financial strategy with corporate objectives while balancing operational realities and market opportunities. His ability to support IPOs, major partnerships, fundraising efforts, and organizational scaling demonstrates a highly strategic and forward-looking leadership approach.
Communication:
An effective communicator who works comfortably with boards, investors, executive teams, and cross-functional stakeholders. He has extensive experience presenting strategic plans, financial insights, and operational recommendations in a clear and actionable manner. His collaborative communication style allows him to build strong relationships while helping organizations make informed and confident decisions.
